跳至主要内容
临床试验/ITMCTR2000004212
ITMCTR2000004212尚未招募未知

The study for acupoint stimulation on preventive treatment of advenocortical function inhibition induced by etomidate: a randomized, double-blind, prospective study.

The Second Affiliated Hospital of Xi'an Jiaotong University0 个研究点开始时间: 待定最近更新:

试验速览

阶段
未知
状态
尚未招募
发起方

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional study

入排标准

年龄范围
18 至 90(—)
性别
All

入选标准

  • Patients must meet all of the following criteria for inclusion in this study:
  • 1. Aged 18-90 years, gender unlimited;
  • 2. ASA range from I to III grade;
  • 3. 18 kg/m24. Clear understanding and voluntary participation in this study.

排除标准

  • 1. Patients with endocrine system diseases such as Kuxing syndrome, pituitary adenoma and adrenal tumor;
  • 2. Patients with hormone drugs within 3 months before operation;
  • 3. Patients with glucocorticoid drugs intraoperatively and postoperatively;
  • 4. Asthma patients;
  • 5. Severe respiratory diseases (obstructive sleep apnea syndrome, acute respiratory infection, acute attack of chronic obstructive pulmonary disease, uncontrolled asthma, active massive hemoptysis, severe pulmonary hypertension, etc);
  • 6. Acute heart failure; unstable angina pectoris; myocardial infarction within 6 months before screening; resting electrocardiogram heart rate < 50 beats / min; third degree atrioventricular block; severe arrhythmia; moderate and severe valvular disease; QTc: male >= 450 ms, female >= 470ms; patients with aortic aneurysm;
  • 7. Infectious heart diseases such as myocarditis or endocarditis; septicemia;
  • 8. People with mental system diseases (schizophrenia, mania, bipolar disorder, insanity, etc.) and long-term history of taking psychotropic drugs and cognitive impairment;
  • 9. Anemia or thrombocytopenia: Hb < 90g/L; PLT < 80x10^9/L;
  • 10. Dysfunction of blood coagulation: PT > ULN +3s and/or APTT > ULN+10s;
  • 11. Liver dysfunction: AST and/or ALT >= 2.5 x ULN, TBIL >= 1.5 x ULN;
  • 12. Renal dysfunction: urea or urea nitrogen >= 1.5x ULN, serum creatinine greater than the upper limit of normal value;
  • 13. There was a history of substance abuse, drug abuse and alcohol abuse within two years prior to the screening period, with alcohol consumption, i.e. drinking more than 2 units of alcohol per day on average (1 unit =360 ml beer or 45 ml liquor with 40% alcohol or 150 wine);
  • 14. Patients who did not receive regular hypotension or have poor blood pressure control (sitting systolic blood pressure >= 160 mmHg or 90 mmHg, and / or 100 mmHg diastolic blood pressure during screening);
  • 15. Patients whose blood glucose was not satisfactorily controlled (random blood glucose >= 11.1 mmol/l);
  • 16. Allergic or contraindicated drugs such as benzodiazepines, opioids, etomidate, propofol and their components;
  • 17. Patients identified as having difficulties in respiratory management (modified Mallampati ? grade);
  • 18. Participated in any clinical drug trial and used the trial drug as a subject in the last 3 months;
  • 19. Patients who could undergo adrenal surgery;
  • 20. Contraindications of trauma and infection in acupuncture and moxibustion puncture site;
  • 21. Other factors that may interfere with the results.

研究者

发起方
The Second Affiliated Hospital of Xi'an Jiaotong University

相似试验

The study for acupoint stimulation on preventive... | 临床试验